The effect of SGLT2 inhibitor on glomrular hyperfiltration in type 2 diabetes patients.
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Aug 2017 Status changed from not yet recruiting to recruiting.
- 11 Apr 2017 New trial record